Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 May 2019 | Story Selloane Mile | Photo Tsepo Moeketsi
Qwaqwa Campus Open Day
Colourful learners from near and far descended on the Qwaqwa Campus for this year’s Open Day.

The 2019 University of the Free State Open Day on the Qwaqwa Campus was a colourful affair, attended by learners from high schools in and around Qwaqwa. Leaners were treated to information tables that saw a display of activities, highlighting the multifaceted nature of the campus, dubbed ‘the education hub in the mountains’. The first session began with an excited crowd of mainly Grade 12s receiving words of encouragement from the Campus Principal, Dr Martin Mandew, who extended a word of welcome and gratitude to the teachers for responding to their call. He also encouraged learners to apply as early as possible for the 2020 academic year, as space in tertiary institutions is limited.
 
“Your future is here; Qwaqwa Campus is the place to be,” he reassured the learners. He concluded by saying, “Ours is a smart campus, well-resourced with information and communication technology facilities, among many other features”. 

Learners explore campus

In the second session, learners explored the campus to learn more about what is being offered. They were met by warm and welcoming smiles from representatives of all the faculties and departments. Support services sharing information with potential students included Housing and Residence Affairs, the Student Representative Council (SRC), Student Life, and KovsieSport. Pretty Nzong, a learner from the Seotlong Agricultural and Hotel School, said she has learnt a lot, especially from the faculties, as she did not know what she wanted to study next year. “My highlight of the day was the inspiration I drew from the Assistant Deans and Campus Management in their academic regalia. I hope one day I will ascend that very stage as a graduate,” she said. Her friend, Lebohang Motsoeneng, said the experience gave her a sense of direction on the career path she wants to follow, and this experience re-ignited her spark to become a natural scientist.

Student Life

Although academy was the centre of attention on the day, learners also experienced ‘the feeling’ said to be only known by Kovsies, as they indulged in the essence of student life, including sports, student leadership, counselling services, and career guidance.
 
A sports fanatic, Moleleki Motaung from Mmathabo Secondary School, alluded to his experience as ‘exciting’. “I have been struggling to get exposure, and I believe this campus will afford me an opportunity to showcase my talent on the football field.”  Kamohelo Pholohang, also from Mmathabo Secondary, said the experience was enlightening, as it dealt with his indecisiveness on the course of study that he wants to pursue next year. Both learners emphasised that they are definitely coming to study here next year; both will be studying for a Bachelor of Education degree, with the former reiterating that he will also be the campus football star!

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept